North China Pharmaceutical Hits Day Low Amid Price Pressure, Closes at CNY 5.01

North China Pharmaceutical Co., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant decline today, with its stock price dropping by 6.08%. The stock reached an intraday low of CNY 5.01, reflecting broader market trends as the China Shanghai Composite index fell by 3.63% on the same day. Over the past week, North China Pharmaceutical has seen a 10.05% decrease, while its performance over the last month shows a decline of 7.27%. Year-to-date, the stock is down 7.78%, and its one-year performance stands at a notable loss of 19.05%. In comparison, the China Shanghai Composite has shown a positive return of 13.33% over the past year. Financial metrics indicate that the company has a Return on Capital Employed (ROCE) of 3.23% and a Return on Equity (ROE) of 5.09%. The stock's Price to Book ratio is 1.63, and it carries a Debt to Equity ratio of 1.78. Despite a high dividend yield of 0.57%, the company has faced challenges in maintaining growth, with net sales declining at an annual rate of 3.15% over the last five years.